Pfizer Declares 24-Cent Third-Quarter 2013 Dividend
Board of Directors Authorizes New $10 Billion Share Repurchase Program
NEW YORK -- June 27, 2013
The board of directors of Pfizer Inc. today declared a 24-cent third-quarter
2013 dividend on the company’s common stock, payable September 4, 2013, to
shareholders of record at the close of business on August 2, 2013. The
third-quarter 2013 cash dividend will be the 299^th consecutive quarterly
dividend paid by Pfizer.
In addition, the board of directors has authorized a new $10 billion share
repurchase program to be utilized over time. This new program is in addition
to the $3.9 billion of authorization remaining under the company’s current
share repurchase program.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring therapies to
people that extend and significantly improve their lives. We strive to set the
standard for quality, safety and value in the discovery, development and
manufacture of health care products. Our global portfolio includes medicines
and vaccines as well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and emerging
markets to advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our responsibility as
one of the world's premier innovative biopharmaceutical companies, we
collaborate with health care providers, governments and local communities to
support and expand access to reliable, affordable health care around the
world. For more than 150 years, Pfizer has worked to make a difference for all
who rely on us. To learn more, please visit us at www.pfizer.com.
Joan Campion, 212-733-2798
Suzanne Harnett, 212-733-8009
Press spacebar to pause and continue. Press esc to stop.